545 related articles for article (PubMed ID: 31494298)
1. MiR-142a-3p alleviates Escherichia coli derived lipopolysaccharide-induced acute lung injury by targeting TAB2.
Yang Y; Yang C; Guo YF; Liu P; Guo S; Yang J; Zahoor A; Shaukat A; Deng G
Microb Pathog; 2019 Nov; 136():103721. PubMed ID: 31494298
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway.
Wang T; Jiang L; Wei X; Dong Z; Liu B; Zhao J; Wang L; Xie P; Wang Y; Zhou S
Cell Cycle; 2019 Aug; 18(16):1893-1907. PubMed ID: 31208297
[TBL] [Abstract][Full Text] [Related]
4. miRNA-206-3p alleviates LPS-induced acute lung injury via inhibiting inflammation and pyroptosis through modulating TLR4/NF-κB/NLRP3 pathway.
Chen M; Zhang J; Huang H; Wang Z; Gao Y; Liu J
Sci Rep; 2024 May; 14(1):11860. PubMed ID: 38789583
[TBL] [Abstract][Full Text] [Related]
5. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
6. MiR-124-3p targeting PDE4B attenuates LPS-induced ALI through the TLR4/NF-κB signaling pathway.
Zhou Q; He DX; Deng YL; Wang CL; Zhang LL; Jiang FM; Irakoze L; Liang ZA
Int Immunopharmacol; 2022 Apr; 105():108540. PubMed ID: 35063752
[TBL] [Abstract][Full Text] [Related]
7. Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-κB pathway.
Yang Y; Li L
J Drug Target; 2021 Apr; 29(4):420-429. PubMed ID: 33185125
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
9. Suppressed nuclear factor-kappa B alleviates lipopolysaccharide-induced acute lung injury through downregulation of CXCR4 mediated by microRNA-194.
Chen R; Xie F; Zhao J; Yue B
Respir Res; 2020 Jun; 21(1):144. PubMed ID: 32522221
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of miR-let-7e attenuates LPS-induced acute lung injury in mice via inhibiting pulmonary inflammation by targeting SCOS1/NF-κB pathway.
Li W; Zhang W; Liu J; Han Y; Jiang H; Ji G; Liu W
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33392621
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-106a Provides Negative Feedback Regulation in Lipopolysaccharide-Induced Inflammation by targeting TLR4.
Yang J; Chen Y; Jiang K; Yang Y; Zhao G; Guo S; Deng G
Int J Biol Sci; 2019; 15(11):2308-2319. PubMed ID: 31595149
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of long non-coding RNA SNHG14 protects against acute lung injury induced by lipopolysaccharide through microRNA-34c-3p-dependent inhibition of WISP1.
Zhu J; Bai J; Wang S; Dong H
Respir Res; 2019 Oct; 20(1):233. PubMed ID: 31660971
[TBL] [Abstract][Full Text] [Related]
13. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
14. LncRNA XIST knockdown alleviates LPS-induced acute lung injury by inactivation of XIST/miR-132-3p/MAPK14 pathway : XIST promotes ALI via miR-132-3p/MAPK14 axis.
Li C; Liu JH; Su J; Lin WJ; Zhao JQ; Zhang ZH; Wu Q
Mol Cell Biochem; 2021 Dec; 476(12):4217-4229. PubMed ID: 34346000
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA MEG3 protects against sepsis-induced acute lung injury in mice through miR-93-5p-dependent inhibition of NF‑κB signaling pathway.
Gao H; Zhang X; Tang F; Chen L; Tian Z; Xiao D; Li X
Pathol Res Pract; 2022 Nov; 239():154142. PubMed ID: 36242967
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-182 supplies negative feedback regulation to ameliorate lipopolysaccharide-induced ALI in mice by targeting TLR4.
Yang J; Chen Y; Jiang K; Zhao G; Guo S; Liu J; Yang Y; Deng G
J Cell Physiol; 2020 Sep; 235(9):5925-5937. PubMed ID: 32003008
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA‑17 contributes to the suppression of the inflammatory response in lipopolysaccharide‑induced acute lung injury in mice via targeting the toll‑like receptor 4/nuclear factor‑κB pathway.
Fu S
Int J Mol Med; 2020 Jul; 46(1):131-140. PubMed ID: 32626914
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3.
Yi X; Wei X; Lv H; An Y; Li L; Lu P; Yang Y; Zhang Q; Yi H; Chen G
Exp Cell Res; 2019 Oct; 383(2):111454. PubMed ID: 31170401
[TBL] [Abstract][Full Text] [Related]
19. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway.
Wu X; Lin L; Wu H
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22664. PubMed ID: 33140555
[TBL] [Abstract][Full Text] [Related]
20. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
